Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine

The combination of cisplatin and gemcitabine is still one of the most frequently used first-line chemotherapy scheme in patients with advanced non-small cell lung cancer (NSCLC), in which tyrosine kinase inhibitors (TKIs) cannot be administered. Unfortunately, more than half of the patients have no...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pathol Oncol Res
Glavni autori: Mlak, Radosław, Krawczyk, Paweł, Homa-Mlak, Iwona, Powrózek, Tomasz, Ciesielka, Marzanna, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Format: Artigo
Jezik:Inglês
Izdano: Springer Netherlands 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614130/
https://ncbi.nlm.nih.gov/pubmed/30066234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-018-0459-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items